- Corporate Officers - B
- Barker Sam L
Insider Trading History of Barker Sam L
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Barker Sam L since 2008.
This trader's CIK number is 1226877.
At the time of last reporting, Barker Sam L was the Director of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX).
Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..
Note that in the past
BARKER SAM L also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Lexicon Pharmaceuticals, Inc. (LXRX) by Barker Sam L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LXRX | 0 | $0 | 0 | $0 | 36,810 | $0 |
| 2024 | LXRX | 0 | $0 | 0 | $0 | 8,032 | $0 |
| 2023 | LXRX | 0 | $0 | 0 | $0 | 9,302 | $0 |
| 2022 | LXRX | 0 | $0 | 0 | $0 | 4,024 | $0 |
| 2020 | LXRX | 0 | $0 | 0 | $0 | 3,466 | $0 |
| 2019 | LXRX | 24,000 | $28,200 | 0 | $0 | 0 | $0 |
| 2017 | LXRX | 1,000 | $12,500 | 0 | $0 | 0 | $0 |
| 2011 | LXRX | 0 | $0 | 0 | $0 | 34,000 | $38,420 |
| 2009 | LXRX | 19,000 | $29,735 | 0 | $0 | 0 | $0 |
| 2008 | LXRX | 40,000 | $78,720 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cyclacel Pharmaceuticals, Inc. (CYCC) by Barker Sam L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | CYCC | 1,000 | $5,000 | 12 | $42 | 0 | $0 |
| 2014 | CYCC | 3,100 | $9,300 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cadence Pharmaceuticals Inc (CADX) by Barker Sam L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | CADX | 9,000 | $63,333 | 0 | $0 | 0 | $0 |
| 2008 | CADX | 11,000 | $57,860 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Atherogenics Inc (AGIX) by Barker Sam L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | AGIX | 0 | $0 | 26,000 | $910 | 0 | $0 |
| 2008 | AGIX | 25,000 | $9,750 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Barker Sam L:
1. Lexicon Pharmaceuticals, Inc. (LXRX)
2. Cyclacel Pharmaceuticals, Inc. (CYCC)
3. Cadence Pharmaceuticals Inc (CADX)
4. Atherogenics Inc (AGIX)
Table 1. Insider trading of Lexicon Pharmaceuticals, Inc. (LXRX) by Barker Sam L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-13 | LXRX | Option Ex | 36,810 | .00 | 0 |
| 2024-04-28 | LXRX | Option Ex | 8,032 | .00 | 0 |
| 2023-05-21 | LXRX | Option Ex | 9,302 | .00 | 0 |
| 2022-04-30 | LXRX | Option Ex | 4,024 | .00 | 0 |
| 2020-04-26 | LXRX | Option Ex | 3,466 | .00 | 0 |
| 2019-08-02 | LXRX | Buy | 24,000 | 1.18 | 28,200 |
| 2017-09-15 | LXRX | Buy | 1,000 | 12.50 | 12,500 |
| 2011-12-22 | LXRX | Option Ex | 34,000 | 1.13 | 38,420 |
| 2009-10-22 | LXRX | Buy | 19,000 | 1.56 | 29,735 |
| 2008-04-18 | LXRX | Buy | 40,000 | 1.97 | 78,720 |
Table 2. Insider trading of Cyclacel Pharmaceuticals, Inc. (CYCC) by Barker Sam L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-30 | CYCC | Sale | 12 | 3.57 | 42 |
| 2021-08-24 | CYCC | Buy | 1,000 | 5.00 | 5,000 |
| 2014-11-20 | CYCC | Buy | 3,100 | 3.00 | 9,300 |
Table 3. Insider trading of Cadence Pharmaceuticals Inc (CADX) by Barker Sam L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-05-10 | CADX | Buy | 9,000 | 7.04 | 63,333 |
| 2008-03-17 | CADX | Buy | 11,000 | 5.26 | 57,860 |
Table 4. Insider trading of Atherogenics Inc (AGIX) by Barker Sam L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-02-04 | AGIX | Sale | 26,000 | .04 | 910 |
| 2008-01-25 | AGIX | Buy | 25,000 | .39 | 9,750 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Barker Sam L
(Director of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.